MedPath

Creatine Supplementation in Autism Spectrum Disorder

Not Applicable
Active, not recruiting
Conditions
Autism Spectrum Disorder
Interventions
Dietary Supplement: Creatine
Registration Number
NCT04498078
Lead Sponsor
University of Novi Sad, Faculty of Sport and Physical Education
Brief Summary

Autism Spectrum Disorder (ASD) is accompanied by reduced levels of total creatine in right temporal-parietal junction and other brain regions of interest, and addressing this deficit by exogenous administration of creatine may have beneficial effects on brain metabolism and disease-specific clinical symptoms in patients suffering from ASD.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Age 10 years and above
  • Informed consent signed by a parent or legal guardian or legal representative
  • Diagnostic and Statistical Manual of Mental Disorders-IV criteria for ASD.
Exclusion Criteria
  • Pregnant or nursing female patients
  • Non-pharmacologic therapy
  • Current diagnosis of other mental disorder

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
CreatineCreatineTwenty grams per day b.i.d.
Primary Outcome Measures
NameTimeMethod
Brain creatine changeChange from Baseline Brain Creatine Levels at 6 Months

Monitor change in brain creatine levels by magnetic resonance imaging

Secondary Outcome Measures
NameTimeMethod
Autism Treatment Evaluation Checklist (ATEC) scoreChange from Baseline ATEC Scores at 6 Months

Monitor changes in ASD severity

Brain N-acetylaspartate changeChange from Baseline Brain N-acetylaspartate Levels at 6 Months

Monitor change in brain N-acetylaspartate levels by magnetic resonance imaging

Trial Locations

Locations (1)

FSPE Applied Bioenergetics Lab

🇷🇸

Novi Sad, Vojvodina, Serbia

© Copyright 2025. All Rights Reserved by MedPath